Barentz International, a leading global life science and performance materials ingredients distributor, has acquired the trade assets of Biogredia, a distributor of premium, branded functional ingredients to the European nutritional supplement and sports nutrition markets.
WHO: Operating from Sandefjord, Norway, Biogredia leverages a strong reputation in the nutraceuticals segment driven by its focus on partnering with high-quality brand owners, a well-balanced product portfolio, and outstanding levels of service.
Barentz is a leading global life science and specialty performance ingredients distributor. The company sources branded specialty ingredients from leading manufacturers worldwide, and its ingredient experts provide value-added technical support, which includes pre-mixing, blending, ingredient formulation, and ingredient testing from its state-of-the-art customized formulation centers and application laboratories in EMEA, Americas, and Asia-Pacific.
Established in 1953, Barentz has operations in more than 70 countries with a strong presence in Europe and North America, and a rapidly growing network in Latin America and Asia-Pacific. With a turnover of circa €2.5 billion, the company employs around 2,600 people worldwide and serves over 25,000 customers.
WHY: The acquisition of Biogredia will significantly strengthen Barentz' value-added product offering of premium, branded nutraceutical ingredients. This aligns with Barentz' strategy to grow in the global nutraceuticals markets.
IN THEIR OWN WORDS: Hidde van der Wal, CEO of Barentz, commented, "After the acquisition of Natural Ingredients last year, we started a separate business line for Nutraceuticals. Biogredia fits perfectly in the next step in our strategy. Bengt Hansson and his team believe in the same business principles as Barentz and together we will grow our position as a premium distributor in the important and attractive nutraceutical segment."
Bengt Hansson, founder of Biogredia, added, "Our team indeed operates in line with the same business values as Barentz and their nutraceutical business approach for EMEA offers a lot of chances for further growth, together. Our Barentz portfolio will be impressive and strong. We are looking forward to entering this new era as part of Barentz, a great global company and strong brand."
DETAILS:
